CADX

Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Financial Results

[PR Newswire] – SAN DIEGO, Feb. 28, 2014 /PRNewswire/ — Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products … moreView todays social media effects on CADXView the latest stocks trending across Twitter. Click to view dashboardSee who Cadence is hiring next, click here to view […]

SHAREHOLDER DEADLINE: Law Office of Brodsky & Smith, LLC Announces Investigation of Cadence Pharmaceuticals, Inc. in Connection With the Sale of the Company to Mallinckrodt plc

[Business Wire] – Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Cadence Pharmaceuticals, Inc. (“Cadence” or the “Compan moreView todays social media effects on CADXView the latest stocks trending across Twitter. Click to view dashboardSee who Cadence is hiring next, click here to view […]

SHAREHOLDER DEADLINE: Law Office of Brodsky & Smith, LLC Announces Investigation of Cadence Pharmaceuticals, Inc.

[Business Wire] – Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Cadence Pharmaceuticals, Inc. (“Cadence” or the “Compan moreView todays social media effects on CADXView the latest stocks trending across Twitter. Click to view dashboardSee who Cadence is hiring next, click here to view […]

INVESTOR ALERT: LEVI & KORSINSKY, LLP Announces Investigation of CADENCE PHARMACEUTICALS INC. and Its Board of Directors in Connection with the Sale of the Company to Mallinckrodt plc — CADX

[Business Wire] – Levi & Korsinsky is investigating the Board of Directors of Cadence Pharmaceuticals Inc. for possible breaches of fiduciary duty an moreView todays social media effects on CADXView the latest stocks trending across Twitter. Click to view dashboardSee who Cadence is hiring next, click here to view […]

CADENCE INVESTOR ALERT: Faruqi & Faruqi, LLP is Investigating Cadence Pharmaceuticals, Inc. (CADX) in Relation to the Proposed Sale of the Company to Mallinckrodt plc

[Business Wire] – Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Cadence Pharmaceuticals, Inc. moreView todays social media effects on CADXView the latest stocks trending across Twitter. Click to view dashboardSee who Cadence is hiring next, click here to view […]

Everyone Wins in This Big Pharma Buyout

moreView todays social media effects on CADXView the latest stocks trending across Twitter. Click to view dashboardSee who Cadence is hiring next, click here to view […]

SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Cadence Pharmaceuticals, Inc. – CADX

[PR Newswire] – BALA CYNWYD, Pa., Feb. 12, 2014 /PRNewswire/ — Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Cadence Pharmaceuticals, Inc. (Candence or the Company) (Nasdaq –CA moreView todays social media effects on CADXView the latest stocks trending across Twitter. Click to view dashboardSee who Cadence is […]